Literature DB >> 12960250

Phosphatidylserine expression and phagocytosis of apoptotic thymocytes during differentiation of monocytic cells.

Melissa K Callahan1, Margaret S Halleck, Stephen Krahling, Andrew J Henderson, Patrick Williamson, Robert A Schlegel.   

Abstract

Expression of phosphatidylserine (PS) on the surface of both macrophages and their apoptotic targets is required for efficient phagocytosis. Monocytes, the precursors of macrophages, do not express PS on their surface and do not efficiently phagocytose apoptotic cells. We report here that PS appears on the surface of both human monocytic U937 cells and primary human monocytes as they differentiate in culture and acquire the ability to phagocytose apoptotic thymocytes. Phagocytosis was blocked by pretreating either the apoptotic target or the phagocyte with annexin V to mask PS and was CD14-dependent. Expression of PS, like other events characteristic of differentiating monocytes such as Mac-1 expression, was independent of the agent used to induce differentiation and was insensitive to the addition of caspase inhibitors. These results demonstrate that PS is expressed on monocytes as part of their differentiation program and is independent of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960250     DOI: 10.1189/jlb.0902433

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  26 in total

1.  Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes.

Authors:  Xiaoxuan Fan; Stephen Krahling; Douglas Smith; Patrick Williamson; Robert A Schlegel
Journal:  Mol Biol Cell       Date:  2004-04-02       Impact factor: 4.138

2.  Phagocytotic competence of differentiated U937 cells for colloidal drug delivery systems in immune cells.

Authors:  Jacqueline Lessig; Björn Neu; Hans-Jürgen Glander; Jürgen Arnhold; Uta Reibetanz
Journal:  Inflammation       Date:  2011-04       Impact factor: 4.092

3.  CED-1, CED-7, and TTR-52 regulate surface phosphatidylserine expression on apoptotic and phagocytic cells.

Authors:  James Mapes; Yu-Zen Chen; Anna Kim; Shohei Mitani; Byung-Ho Kang; Ding Xue
Journal:  Curr Biol       Date:  2012-06-21       Impact factor: 10.834

4.  Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

Authors:  R Lee Mosley; Eric J Benner; Irena Kadiu; Mark Thomas; Michael D Boska; Khader Hasan; Chad Laurie; Howard E Gendelman
Journal:  Clin Neurosci Res       Date:  2006-12-06

5.  Phosphatidylserine as an anchor for plasminogen and its plasminogen receptor, histone H2B, to the macrophage surface.

Authors:  R Das; E F Plow
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

6.  Inhibition of macrophage apoptosis by Neisseria meningitidis requires nitric oxide detoxification mechanisms.

Authors:  Anne J Tunbridge; Tania M Stevanin; Margaret Lee; Helen M Marriott; James W B Moir; Robert C Read; David H Dockrell
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

7.  Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells.

Authors:  Tomasz P Mikołajczyk; Joanna E Skrzeczyńska-Moncznik; Mirosław A Zarebski; Ewa A Marewicz; Anna M Wiśniewska; Magdalena Dzieba; Jerzy W Dobrucki; Juliusz R Pryjma
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

Review 8.  Apoptosis and beyond: cytometry in studies of programmed cell death.

Authors:  Donald Wlodkowic; William Telford; Joanna Skommer; Zbigniew Darzynkiewicz
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

Review 9.  New insights into the role of Plg-RKT in macrophage recruitment.

Authors:  Lindsey A Miles; Shahrzad Lighvani; Nagyung Baik; Caitlin M Parmer; Sophia Khaldoyanidi; Barbara M Mueller; Robert J Parmer
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

Review 10.  Plasminogen receptors: the first quarter century.

Authors:  Lindsey A Miles; Robert J Parmer
Journal:  Semin Thromb Hemost       Date:  2013-03-26       Impact factor: 4.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.